Charles Schwab’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
518,628
+14,931
| +3% | +$36.9K | ﹤0.01% | 2823 |
|
|
2025
Q1 | $1M | Buy |
503,697
+19,106
| +4% | +$38K | ﹤0.01% | 2843 |
|
|
2024
Q4 | $1.42M | Buy |
484,591
+20,614
| +4% | +$60.2K | ﹤0.01% | 2790 |
|
|
2024
Q3 | $1.8M | Sell |
463,977
-28,284
| -6% | -$109K | ﹤0.01% | 2742 |
|
|
2024
Q2 | $2.53M | Buy |
492,261
+194,438
| +65% | +$999K | ﹤0.01% | 2622 |
|
|
2024
Q1 | $2.08M | Buy |
297,823
+1,635
| +0.6% | +$11.4K | ﹤0.01% | 2581 |
|
|
2023
Q4 | $2.62M | Buy |
296,188
+3,618
| +1% | +$32.1K | ﹤0.01% | 2531 |
|
|
2023
Q3 | $2.79M | Buy |
292,570
+151,426
| +107% | +$1.44M | ﹤0.01% | 2501 |
|
|
2023
Q2 | $2.07M | Buy |
141,144
+67,717
| +92% | +$992K | ﹤0.01% | 2539 |
|
|
2023
Q1 | $903K | Buy |
73,427
+2,243
| +3% | +$27.6K | ﹤0.01% | 2766 |
|
|
2022
Q4 | $1.32M | Buy |
+71,184
| New | +$1.32M | ﹤0.01% | 2687 |
|